The market really wants to carry on going up and there is a lot of optimism about this results season. We're not as confident as a lot of others because we think the economic fundamentals are still showing signs of weakness.
I think it's still a very important piece of legislation. The importance is the preservation of the eligibility for funding for embryonic stem cell research.
You're getting rid of the disease in the bone marrow. I think that the efficacy is unquestionable.
We welcome the surprise announcement from the governor, coupled with House Bill 1, which has language that will ensure scientific integrity and ensure this money is given out on a scientific, peer-review basis. It's huge for the community.
